CN107164457A - A kind of high-throughput screening method of New-type wide-spectrum lysozyme - Google Patents
A kind of high-throughput screening method of New-type wide-spectrum lysozyme Download PDFInfo
- Publication number
- CN107164457A CN107164457A CN201710284625.9A CN201710284625A CN107164457A CN 107164457 A CN107164457 A CN 107164457A CN 201710284625 A CN201710284625 A CN 201710284625A CN 107164457 A CN107164457 A CN 107164457A
- Authority
- CN
- China
- Prior art keywords
- lysozyme
- fluorescent protein
- protease
- gene
- target
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 title claims abstract description 89
- 108010014251 Muramidase Proteins 0.000 title claims abstract description 88
- 235000010335 lysozyme Nutrition 0.000 title claims abstract description 74
- 229960000274 lysozyme Drugs 0.000 title claims abstract description 67
- 239000004325 lysozyme Substances 0.000 title claims abstract description 67
- 238000000034 method Methods 0.000 title claims abstract description 39
- 102000016943 Muramidase Human genes 0.000 title claims abstract description 12
- 238000013537 high throughput screening Methods 0.000 title claims abstract description 9
- 238000001228 spectrum Methods 0.000 title claims 2
- 241000894006 Bacteria Species 0.000 claims abstract description 42
- 108091006047 fluorescent proteins Proteins 0.000 claims abstract description 40
- 102000034287 fluorescent proteins Human genes 0.000 claims abstract description 38
- 238000006243 chemical reaction Methods 0.000 claims abstract description 33
- 239000004365 Protease Substances 0.000 claims abstract description 25
- 108091005804 Peptidases Proteins 0.000 claims abstract description 23
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 claims abstract description 19
- 230000000844 anti-bacterial effect Effects 0.000 claims abstract description 19
- 230000000694 effects Effects 0.000 claims abstract description 16
- 238000012216 screening Methods 0.000 claims abstract description 14
- 206010064571 Gene mutation Diseases 0.000 claims abstract description 9
- 239000011535 reaction buffer Substances 0.000 claims abstract description 3
- 230000003248 secreting effect Effects 0.000 claims abstract 2
- 108090000623 proteins and genes Proteins 0.000 claims description 38
- 108010076818 TEV protease Proteins 0.000 claims description 23
- 238000012546 transfer Methods 0.000 claims description 15
- 108010082025 cyan fluorescent protein Proteins 0.000 claims description 14
- 239000000243 solution Substances 0.000 claims description 14
- 102000004169 proteins and genes Human genes 0.000 claims description 11
- 102000004190 Enzymes Human genes 0.000 claims description 7
- 108090000790 Enzymes Proteins 0.000 claims description 7
- 241000235058 Komagataella pastoris Species 0.000 claims description 7
- 229940088598 enzyme Drugs 0.000 claims description 7
- 230000012010 growth Effects 0.000 claims description 7
- 238000010276 construction Methods 0.000 claims description 6
- 239000012530 fluid Substances 0.000 claims description 4
- 108010074860 Factor Xa Proteins 0.000 claims description 2
- 230000003834 intracellular effect Effects 0.000 claims description 2
- 108010047357 Luminescent Proteins Proteins 0.000 claims 1
- 102000006830 Luminescent Proteins Human genes 0.000 claims 1
- 108091000080 Phosphotransferase Proteins 0.000 claims 1
- 125000003275 alpha amino acid group Chemical group 0.000 claims 1
- 210000000936 intestine Anatomy 0.000 claims 1
- 239000010985 leather Substances 0.000 claims 1
- 102000020233 phosphotransferase Human genes 0.000 claims 1
- 230000008521 reorganization Effects 0.000 claims 1
- 238000000855 fermentation Methods 0.000 abstract description 23
- 230000004151 fermentation Effects 0.000 abstract description 23
- 210000004027 cell Anatomy 0.000 abstract description 21
- 238000001514 detection method Methods 0.000 abstract description 15
- 238000002866 fluorescence resonance energy transfer Methods 0.000 abstract description 12
- 210000003527 eukaryotic cell Anatomy 0.000 abstract description 5
- 102000035195 Peptidases Human genes 0.000 abstract description 3
- 230000035945 sensitivity Effects 0.000 abstract description 3
- 235000010633 broth Nutrition 0.000 abstract 2
- 102100033468 Lysozyme C Human genes 0.000 description 56
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 21
- 239000013612 plasmid Substances 0.000 description 20
- 230000001580 bacterial effect Effects 0.000 description 18
- 239000000203 mixture Substances 0.000 description 18
- 239000000499 gel Substances 0.000 description 16
- 101001018100 Homo sapiens Lysozyme C Proteins 0.000 description 13
- 239000012634 fragment Substances 0.000 description 13
- 239000000047 product Substances 0.000 description 13
- 239000000725 suspension Substances 0.000 description 12
- 241000255789 Bombyx mori Species 0.000 description 11
- 210000002421 cell wall Anatomy 0.000 description 10
- 239000013613 expression plasmid Substances 0.000 description 9
- 239000002609 medium Substances 0.000 description 9
- 108091005957 yellow fluorescent proteins Proteins 0.000 description 9
- 241000588724 Escherichia coli Species 0.000 description 8
- 239000006228 supernatant Substances 0.000 description 8
- 239000000758 substrate Substances 0.000 description 7
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 6
- 238000000246 agarose gel electrophoresis Methods 0.000 description 6
- 239000000872 buffer Substances 0.000 description 6
- 238000001962 electrophoresis Methods 0.000 description 6
- 238000001976 enzyme digestion Methods 0.000 description 6
- 239000008223 sterile water Substances 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 5
- 239000006285 cell suspension Substances 0.000 description 5
- 239000007788 liquid Substances 0.000 description 5
- 230000035772 mutation Effects 0.000 description 5
- 238000011084 recovery Methods 0.000 description 5
- 238000011144 upstream manufacturing Methods 0.000 description 5
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
- MSFSPUZXLOGKHJ-UHFFFAOYSA-N Muraminsaeure Natural products OC(=O)C(C)OC1C(N)C(O)OC(CO)C1O MSFSPUZXLOGKHJ-UHFFFAOYSA-N 0.000 description 4
- 108010013639 Peptidoglycan Proteins 0.000 description 4
- 244000052616 bacterial pathogen Species 0.000 description 4
- 238000004520 electroporation Methods 0.000 description 4
- 239000013604 expression vector Substances 0.000 description 4
- PHTQWCKDNZKARW-UHFFFAOYSA-N isoamylol Chemical compound CC(C)CCO PHTQWCKDNZKARW-UHFFFAOYSA-N 0.000 description 4
- 238000003259 recombinant expression Methods 0.000 description 4
- 108091008146 restriction endonucleases Proteins 0.000 description 4
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 3
- 101001054905 Homo sapiens Lysozyme-like protein 4 Proteins 0.000 description 3
- 241001506991 Komagataella phaffii GS115 Species 0.000 description 3
- 238000000862 absorption spectrum Methods 0.000 description 3
- 150000001413 amino acids Chemical group 0.000 description 3
- 238000000137 annealing Methods 0.000 description 3
- 238000005119 centrifugation Methods 0.000 description 3
- 239000008367 deionised water Substances 0.000 description 3
- 229910021641 deionized water Inorganic materials 0.000 description 3
- 238000004925 denaturation Methods 0.000 description 3
- 230000036425 denaturation Effects 0.000 description 3
- 238000000295 emission spectrum Methods 0.000 description 3
- 239000002158 endotoxin Substances 0.000 description 3
- BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl beta-D-thiogalactopyranoside Chemical compound CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 description 3
- 229920006008 lipopolysaccharide Polymers 0.000 description 3
- 239000013642 negative control Substances 0.000 description 3
- 238000012257 pre-denaturation Methods 0.000 description 3
- 239000000600 sorbitol Substances 0.000 description 3
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 2
- 241000238631 Hexapoda Species 0.000 description 2
- 238000012408 PCR amplification Methods 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 239000011543 agarose gel Substances 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 229930027917 kanamycin Natural products 0.000 description 2
- 229960000318 kanamycin Drugs 0.000 description 2
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 2
- 229930182823 kanamycin A Natural products 0.000 description 2
- 238000002844 melting Methods 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 101150039504 6 gene Proteins 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 229920000936 Agarose Polymers 0.000 description 1
- 102000006410 Apoproteins Human genes 0.000 description 1
- 108010083590 Apoproteins Proteins 0.000 description 1
- 241000193468 Clostridium perfringens Species 0.000 description 1
- 206010059866 Drug resistance Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 102100029727 Enteropeptidase Human genes 0.000 description 1
- 108010013369 Enteropeptidase Proteins 0.000 description 1
- 241000192125 Firmicutes Species 0.000 description 1
- 102000006395 Globulins Human genes 0.000 description 1
- 108010044091 Globulins Proteins 0.000 description 1
- ZOXBSICWUDAOHX-GUBZILKMSA-N Glu-Asn-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)CCC(O)=O ZOXBSICWUDAOHX-GUBZILKMSA-N 0.000 description 1
- 101000616288 Homo sapiens Lysozyme-like protein 6 Proteins 0.000 description 1
- 241000588747 Klebsiella pneumoniae Species 0.000 description 1
- LHSGPCFBGJHPCY-UHFFFAOYSA-N L-leucine-L-tyrosine Natural products CC(C)CC(N)C(=O)NC(C(O)=O)CC1=CC=C(O)C=C1 LHSGPCFBGJHPCY-UHFFFAOYSA-N 0.000 description 1
- 102100026863 Lysozyme-like protein 4 Human genes 0.000 description 1
- 102100021801 Lysozyme-like protein 6 Human genes 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 241000237852 Mollusca Species 0.000 description 1
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 1
- 241000607768 Shigella Species 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- FDKDGFGTHGJKNV-FHWLQOOXSA-N Tyr-Phe-Gln Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)O)NC(=O)[C@H](CC2=CC=C(C=C2)O)N FDKDGFGTHGJKNV-FHWLQOOXSA-N 0.000 description 1
- 108010067390 Viral Proteins Proteins 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 108010084455 Zeocin Proteins 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000010523 cascade reaction Methods 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 230000032823 cell division Effects 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- YTRQFSDWAXHJCC-UHFFFAOYSA-N chloroform;phenol Chemical compound ClC(Cl)Cl.OC1=CC=CC=C1 YTRQFSDWAXHJCC-UHFFFAOYSA-N 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 238000010367 cloning Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000005336 cracking Methods 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 238000010227 cup method (microbiological evaluation) Methods 0.000 description 1
- 230000009089 cytolysis Effects 0.000 description 1
- 230000007123 defense Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 235000014103 egg white Nutrition 0.000 description 1
- 210000000969 egg white Anatomy 0.000 description 1
- 210000002919 epithelial cell Anatomy 0.000 description 1
- 238000012869 ethanol precipitation Methods 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 101150101299 gene 4 gene Proteins 0.000 description 1
- 108010078144 glutaminyl-glycine Proteins 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 230000006801 homologous recombination Effects 0.000 description 1
- 238000002744 homologous recombination Methods 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 239000002054 inoculum Substances 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 108010012058 leucyltyrosine Proteins 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 239000006166 lysate Substances 0.000 description 1
- 230000002934 lysing effect Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000000155 melt Substances 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 229910021645 metal ion Inorganic materials 0.000 description 1
- 230000004660 morphological change Effects 0.000 description 1
- 229940051921 muramidase Drugs 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- LCCNCVORNKJIRZ-UHFFFAOYSA-N parathion Chemical compound CCOP(=S)(OCC)OC1=CC=C([N+]([O-])=O)C=C1 LCCNCVORNKJIRZ-UHFFFAOYSA-N 0.000 description 1
- CWCMIVBLVUHDHK-ZSNHEYEWSA-N phleomycin D1 Chemical compound N([C@H](C(=O)N[C@H](C)[C@@H](O)[C@H](C)C(=O)N[C@@H]([C@H](O)C)C(=O)NCCC=1SC[C@@H](N=1)C=1SC=C(N=1)C(=O)NCCCCNC(N)=N)[C@@H](O[C@H]1[C@H]([C@@H](O)[C@H](O)[C@H](CO)O1)O[C@@H]1[C@H]([C@@H](OC(N)=O)[C@H](O)[C@@H](CO)O1)O)C=1N=CNC=1)C(=O)C1=NC([C@H](CC(N)=O)NC[C@H](N)C(N)=O)=NC(N)=C1C CWCMIVBLVUHDHK-ZSNHEYEWSA-N 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000006798 recombination Effects 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 229910021642 ultra pure water Inorganic materials 0.000 description 1
- 239000012498 ultrapure water Substances 0.000 description 1
- 238000009423 ventilation Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
- C12Q1/40—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving amylase
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/914—Hydrolases (3)
- G01N2333/924—Hydrolases (3) acting on glycosyl compounds (3.2)
- G01N2333/936—Hydrolases (3) acting on glycosyl compounds (3.2) acting on beta-1, 4 bonds between N-acetylmuramic acid and 2-acetyl-amino 2-deoxy-D-glucose, e.g. lysozyme
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Physics & Mathematics (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Analytical Chemistry (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
本发明涉及分子生物学技术领域的一种新型广谱溶菌酶的高通量筛选方法。该方法包括以下步骤:A,将目标溶菌酶的基因突变文库在真核细胞中进行分泌表达,获得含不同活性目标溶菌酶的发酵液;B,将含不同活性目标溶菌酶的发酵液分别加入到反应体系中进行反应,筛选出对革兰氏阴性菌杀菌活性高的溶菌酶;其中,反应体系包括:胞内表达“供体荧光蛋白‑蛋白酶的识别位点‑受体荧光蛋白”的革兰氏阴性菌、蛋白酶和蛋白酶反应缓冲液。本发明所述筛选方法通过FRET荧光蛋白对与位点特异性蛋白酶的级联,显著提高了检测的灵敏度;同时该方法可利用荧光酶标仪和96微孔板实现溶菌酶的高通量检测。The invention relates to a high-throughput screening method for a novel broad-spectrum lysozyme in the technical field of molecular biology. The method comprises the following steps: A, secreting and expressing the gene mutation library of the target lysozyme in eukaryotic cells to obtain fermentation broths containing target lysozymes with different activities; B, adding the fermentation broths containing target lysozymes with different activities respectively React in the reaction system to screen out lysozymes with high bactericidal activity against Gram-negative bacteria; wherein, the reaction system includes: a target expressing "donor fluorescent protein-protease recognition site-acceptor fluorescent protein" in the cell Lambert-negative bacteria, protease and protease reaction buffer. The screening method of the present invention significantly improves the sensitivity of detection through the cascade of FRET fluorescent protein pairs and site-specific proteases; at the same time, the method can utilize a fluorescent microplate reader and a 96 microwell plate to realize high-throughput detection of lysozyme .
Description
技术领域technical field
本发明属于分子生物学技术领域,具体涉及一种新型广谱溶菌酶的高通量筛选方法。The invention belongs to the technical field of molecular biology, and in particular relates to a high-throughput screening method for novel broad-spectrum lysozyme.
背景技术Background technique
溶菌酶(lysozyme,EC3.2.1.17)又称胞壁质酶(muramidase),能特异性水解原核细菌细胞壁中的主要成分肽聚糖,分解微生物的细胞壁,使细菌失去细胞壁的保护并在胞内高渗透压的作用下破裂死亡,从而达到杀菌目的。1921年,著名英国细菌学家AlexanderFleming在人的鼻液中发现了溶菌酶,后证实溶菌酶广泛存在于鸟类和禽类的蛋清内、哺乳动物的各器官组织和体液内、植物以及软体动物和昆虫体内。Lysozyme (lysozyme, EC3.2.1.17), also known as muramidase, can specifically hydrolyze peptidoglycan, the main component in the cell wall of prokaryotic bacteria, decompose the cell wall of microorganisms, and make the bacteria lose the protection of the cell wall and regenerate in the cell wall. Under the action of internal high osmotic pressure, it ruptures and dies, so as to achieve the purpose of sterilization. In 1921, the famous British bacteriologist Alexander Fleming discovered lysozyme in human nasal fluid, and later confirmed that lysozyme widely exists in the egg whites of birds and birds, various organs and tissues and body fluids of mammals, plants, molluscs and inside the insect.
溶菌酶作为高等有机体组织及体液中最强大的抗菌剂之一,是生物机体对抗外源病原菌侵袭的重要防御因子。如人溶菌酶是一种小分子碱性球蛋白,它由上皮细胞和单核-巨噬细胞分泌,可识别和破坏病原菌的细胞结构,并通过信号级联反应吸引白细胞集中到感染部位,最终消灭侵染人体的病原菌。此外,溶菌酶还可与带负电荷的病毒蛋白直接结合,和DNA-RNA脱辅基蛋白形成复盐,使病毒失活。在植物中,如无花果的鲜汁中均含有丰富的溶菌酶,推测其与植物的抗病毒作用密切关系。另一方面,溶菌酶也广泛存在于微生物中,如各种细菌和噬菌体。噬菌体溶菌酶与噬菌体侵染过程中细菌细胞壁的分解有关。细菌溶菌酶的主要功能是参与细胞生长分裂形态改变等与细胞壁相关的代谢过程。因此,细菌不会对溶菌酶这种细菌中广泛含有的自溶素(autolysin),产生真正意义上的抵抗性,这对于解决日益严峻的细菌耐药性问题,减少抗生素滥用具有重要意义。As one of the most powerful antibacterial agents in higher organism tissues and body fluids, lysozyme is an important defense factor for biological organisms against the invasion of exogenous pathogenic bacteria. For example, human lysozyme is a small molecule basic globulin secreted by epithelial cells and monocyte-macrophages, which can recognize and destroy the cell structure of pathogenic bacteria, and attract leukocytes to the infection site through a signal cascade reaction, eventually Eliminate pathogenic bacteria that infect the human body. In addition, lysozyme can also directly combine with negatively charged viral proteins and form double salts with DNA-RNA apoproteins to inactivate the virus. In plants, such as the fresh juice of figs, lysozyme is rich in lysozyme, which is speculated to be closely related to the antiviral effect of plants. On the other hand, lysozyme also widely exists in microorganisms, such as various bacteria and phages. Phage lysozymes are involved in the breakdown of bacterial cell walls during phage infection. The main function of bacterial lysozyme is to participate in cell wall-related metabolic processes such as cell growth, division, and morphological changes. Therefore, bacteria will not develop true resistance to lysozyme, an autolysin widely contained in bacteria, which is of great significance for solving the increasingly serious problem of bacterial drug resistance and reducing the abuse of antibiotics.
虽然溶菌酶的作用强大,但其对革兰氏阴性菌的裂解效果并不好。这是由于细菌细胞壁构成不同所导致的。革兰氏阳性菌的细胞壁主要由肽聚糖构成,肽聚糖层数较多且较厚,含有少量磷壁酸,而革兰氏阴性菌外层主要由脂多糖(LPS)构成,内层才含有少量肽聚糖。而溶菌酶的主要作用位点为细胞壁中的肽聚糖,水解β-1,4糖苷键,故其对于革兰氏阴性菌的作用效果不是很理想。Although lysozyme is powerful, it is not very effective at lysing Gram-negative bacteria. This is due to the different composition of the bacterial cell wall. The cell wall of Gram-positive bacteria is mainly composed of peptidoglycan, which has many and thick layers and contains a small amount of teichoic acid, while the outer layer of Gram-negative bacteria is mainly composed of lipopolysaccharide (LPS). Contains only a small amount of peptidoglycan. The main action site of lysozyme is the peptidoglycan in the cell wall, which hydrolyzes the β-1,4 glycosidic bond, so its effect on Gram-negative bacteria is not ideal.
在日常生活当中,人们所接触到的很多致病菌,如大肠杆菌、铜绿假单胞菌、肺炎杆菌、痢疾杆菌和产气荚膜杆菌等,都属于革兰氏阴性菌。为了得到对革兰氏阴性菌具有高杀菌活性的溶菌酶,可以对溶菌酶进行定向进化,构建溶菌酶基因随机突变文库,再从中筛选出对革兰氏阴性菌杀菌效果较强的溶菌酶。In daily life, many pathogenic bacteria that people come into contact with, such as Escherichia coli, Pseudomonas aeruginosa, Klebsiella pneumoniae, Shigella and Clostridium perfringens, are all Gram-negative bacteria. In order to obtain lysozyme with high bactericidal activity against Gram-negative bacteria, lysozyme can be subjected to directed evolution to construct a random mutation library of lysozyme gene, and then screen out lysozyme with strong bactericidal effect on Gram-negative bacteria.
定向转化过程中,一方面,所需的突变体文库数量庞大,需采用高通量方法以提高筛选效率;另一方面,溶菌酶对革兰氏阴性菌裂解效果差,需采用衡量指标较敏感、可有效反映裂解效果的筛选手段。而现有的筛选方法如平板抑菌圈法、牛津杯法等,无法很好的同时满足以上两点要求。因此,亟需构建一种灵敏可靠、易操作的高通量筛选方法,用于新型广谱溶菌酶突变体的筛选。In the process of directed transformation, on the one hand, the required mutant library is huge, and a high-throughput method is required to improve the screening efficiency; on the other hand, lysozyme has a poor lysis effect on Gram-negative bacteria, and a sensitive indicator needs to be used. , A screening method that can effectively reflect the cracking effect. However, the existing screening methods, such as plate inhibition zone method and Oxford cup method, cannot satisfy the above two requirements at the same time. Therefore, it is urgent to construct a sensitive, reliable, and easy-to-operate high-throughput screening method for the screening of novel broad-spectrum lysozyme mutants.
发明内容Contents of the invention
本发明所要解决的技术问题是针对现有技术的不足提供一种新型广谱溶菌酶的高通量筛选方法,该方法通过FRET荧光蛋白对与位点特异性蛋白酶的级联使用,提高了检测的灵敏性,同时利用荧光酶标仪和96微孔板可以实现溶菌酶的高通量检测。The technical problem to be solved by the present invention is to provide a high-throughput screening method for a novel broad-spectrum lysozyme for the deficiencies in the prior art. This method improves the detection efficiency by cascading FRET fluorescent protein pairs with site-specific proteases. Sensitivity, and high-throughput detection of lysozyme can be achieved by using a fluorescent microplate reader and a 96-well plate.
为此,本发明提供了一种新型广谱溶菌酶的高通量筛选方法,其包括以下步骤:For this reason, the invention provides a kind of high-throughput screening method of novel broad-spectrum lysozyme, which comprises the following steps:
A,将目标溶菌酶的基因突变文库在真核细胞中进行分泌表达,获得含不同活性目标溶菌酶的发酵液;A, the gene mutation library of the target lysozyme is secreted and expressed in eukaryotic cells, and the fermentation broth containing the target lysozyme with different activities is obtained;
B,将含不同活性目标溶菌酶的发酵液分别加入到反应体系中进行反应,筛选出对革兰氏阴性菌杀菌活性高的溶菌酶;B, adding fermented liquids containing lysozymes with different active targets to the reaction system for reaction, and screening out lysozymes with high bactericidal activity against Gram-negative bacteria;
其中,所述反应体系包括:胞内表达“供体荧光蛋白-蛋白酶的识别位点-受体荧光蛋白”的革兰氏阴性菌、蛋白酶和蛋白酶反应缓冲液。Wherein, the reaction system includes: Gram-negative bacteria expressing "donor fluorescent protein-protease recognition site-acceptor fluorescent protein" in cells, protease and protease reaction buffer.
在本发明中,根据反应过程中供体荧光蛋白的信号强度增长速度,判断发酵液中的溶菌酶对革兰氏阴性菌杀菌活性;具体地,反应过程中供体荧光蛋白的信号强度增长越快,发酵液中的溶菌酶对革兰氏阴性菌杀菌活性越高。In the present invention, according to the signal intensity growth rate of the donor fluorescent protein in the reaction process, the bactericidal activity of lysozyme in the fermentation broth to Gram-negative bacteria is judged; specifically, the faster the signal intensity of the donor fluorescent protein increases in the reaction process Faster, the higher the bactericidal activity of lysozyme in the fermentation broth to Gram-negative bacteria.
在本发明的一些实施方式中,所述的蛋白酶为具有识别序列特异性的蛋白酶;在本发明的一些具体实施例中,所述的蛋白酶为TEV蛋白酶、肠激酶或凝血因子Xa;在本发明的一些优选的实施例中,所述的蛋白酶为TEV蛋白酶。In some embodiments of the present invention, the protease is a protease with recognition sequence specificity; in some specific embodiments of the present invention, the protease is TEV protease, enterokinase or coagulation factor Xa; in the present invention In some preferred embodiments, the protease is TEV protease.
在本发明的另一些实施方式中,所述TEV蛋白酶的识别位点的氨基酸序列为:Glu-Asn-Leu-Tyr-Phe-Gln-Gly。In other embodiments of the present invention, the amino acid sequence of the recognition site of the TEV protease is: Glu-Asn-Leu-Tyr-Phe-Gln-Gly.
在本发明的一些实施方式中,所述目标溶菌酶基因突变文库的构建方法为易错PCR和/或DNA改组。In some embodiments of the present invention, the construction method of the target lysozyme gene mutation library is error-prone PCR and/or DNA shuffling.
在本发明中,由于供体荧光蛋白的发射光谱与受体荧光蛋白的吸收光谱重叠,因此当供体荧光蛋白与受体荧光蛋白之间的距离在10nm以内时,会发生能量转移现象,供体荧光蛋白的能量转移至受体荧光蛋白上,使供体蛋白荧光强度要比它单独存在时低得多,而受体蛋白荧光强度大大增强。In the present invention, since the emission spectrum of the donor fluorescent protein overlaps with the absorption spectrum of the acceptor fluorescent protein, when the distance between the donor fluorescent protein and the acceptor fluorescent protein is within 10 nm, an energy transfer phenomenon occurs, and the donor fluorescent protein The energy of the bulk fluorescent protein is transferred to the acceptor fluorescent protein, so that the fluorescence intensity of the donor protein is much lower than when it exists alone, while the fluorescence intensity of the acceptor protein is greatly enhanced.
在本发明的一些具体实施例中,所述的供体荧光蛋白为青色荧光蛋白,所述的受体荧光蛋白为黄色荧光蛋白。In some specific embodiments of the present invention, the donor fluorescent protein is cyan fluorescent protein, and the acceptor fluorescent protein is yellow fluorescent protein.
在本发明的一些具体实施方式中,所述真核细胞为毕赤酵母。In some embodiments of the invention, the eukaryotic cell is Pichia pastoris.
在本发明的另一些具体实施方式中,所述方法还包括以下步骤:In other specific embodiments of the present invention, the method also includes the following steps:
C,对筛选出的对革兰氏阴性菌杀菌活性高的溶菌酶进行复筛,根据反应过程中供体荧光蛋白的信号强度增长速度,验证溶菌酶的活性。C, re-screening the screened lysozyme with high bactericidal activity against Gram-negative bacteria, and verifying the activity of lysozyme according to the growth rate of the signal intensity of the donor fluorescent protein during the reaction.
本发明的有益效果为:本发明所述筛选方法通过FRET荧光蛋白对与位点特异性蛋白酶的级联,借助检测荧光信号,显著提高了检测的灵敏度,可有效地发现阳性突变,找到优良突变基因;同时该方法可利用荧光酶标仪和96微孔板实现溶菌酶的高通量检测。The beneficial effects of the present invention are: the screening method of the present invention significantly improves the sensitivity of detection through the cascade of FRET fluorescent protein pairs and site-specific proteases by means of detection of fluorescent signals, and can effectively find positive mutations and excellent mutations gene; at the same time, the method can realize high-throughput detection of lysozyme by using a fluorescent microplate reader and a 96-well plate.
具体实施方式detailed description
为使本发明容易理解,下面将详细说明本发明。In order to make the present invention easy to understand, the present invention will be described in detail below.
本发明所述筛选方法基于荧光共振能量转移技术(FRET),即两个荧光蛋白分子距离极近(10nm以内)时,如果供体荧光蛋白的发射光谱与受体荧光蛋白的吸收光谱重叠,则会发生能量转移现象,供体荧光蛋白的能量转移至受体荧光蛋白上,使供体蛋白荧光强度要比它单独存在时低得多,而受体蛋白荧光强度大大增强。以青色荧光蛋白和黄色荧光蛋白为例,青色荧光蛋白和黄色荧光蛋白是一对可以发生FRET效应的蛋白,其中青色蛋白的发射光谱与黄色蛋白的吸收光谱重叠。The screening method of the present invention is based on fluorescence resonance energy transfer technology (FRET), that is, when two fluorescent protein molecules are extremely close (within 10nm), if the emission spectrum of the donor fluorescent protein overlaps with the absorption spectrum of the acceptor fluorescent protein, then The phenomenon of energy transfer will occur, the energy of the donor fluorescent protein is transferred to the acceptor fluorescent protein, so that the fluorescence intensity of the donor protein is much lower than when it exists alone, and the fluorescence intensity of the acceptor protein is greatly enhanced. Taking cyan fluorescent protein and yellow fluorescent protein as an example, cyan fluorescent protein and yellow fluorescent protein are a pair of proteins that can undergo FRET effect, wherein the emission spectrum of cyan protein overlaps with the absorption spectrum of yellow protein.
用蛋白酶的识别位点作为linker序列,例如,采用TEV蛋白酶的识别位点作为linker序列将青色荧光蛋白和黄色荧光蛋白连接,使青色荧光蛋白和黄色荧光蛋白形成距离极近的FRET荧光蛋白对,即“青色荧光蛋白-TEV蛋白酶的识别位点-黄色荧光蛋白”。TEV蛋白酶的识别位点是由Glu-Asn-Leu-Tyr-Phe-Gln-Gly七个氨基酸构成。Use the protease recognition site as the linker sequence, for example, use the TEV protease recognition site as the linker sequence to connect the cyan fluorescent protein and the yellow fluorescent protein, so that the cyan fluorescent protein and the yellow fluorescent protein form a FRET fluorescent protein pair with a very close distance, That is, "cyan fluorescent protein-TEV protease recognition site-yellow fluorescent protein". The recognition site of TEV protease is composed of seven amino acids Glu-Asn-Leu-Tyr-Phe-Gln-Gly.
反应前,由于linker序列(TEV蛋白酶的识别位点)的作用,青色荧光蛋白和黄色荧光蛋白距离极近,青色荧光蛋白的能量转移至黄色荧光蛋白上,此时检测信号呈现青色荧光信号弱、黄色荧光信号强;当将含溶菌酶的发酵液加入反应液中,若溶菌酶对底物菌种(革兰氏阴性菌)有较好的杀菌活性,则细菌发生裂解并释放内部的FRET荧光蛋白对。该蛋白对的TEV蛋白酶的识别位点被反应液中的TEV蛋白酶特异性识别并分解,得到独立的青色荧光蛋白和黄色荧光蛋白,FRET现象消失,使得青色荧光信号增强。因此,可以通过定量测定青色荧光蛋白信号强度的增长速度,来判定溶菌酶对革兰氏阴性菌的杀菌活性。Before the reaction, due to the linker sequence (recognition site of TEV protease), the distance between the cyan fluorescent protein and the yellow fluorescent protein is very close, and the energy of the cyan fluorescent protein is transferred to the yellow fluorescent protein. At this time, the detection signal shows a weak cyan fluorescent signal, The yellow fluorescent signal is strong; when the fermentation broth containing lysozyme is added to the reaction solution, if the lysozyme has good bactericidal activity on the substrate bacteria (Gram-negative bacteria), the bacteria will be lysed and the internal FRET fluorescence will be released protein pair. The recognition site of the TEV protease of the protein pair is specifically recognized and decomposed by the TEV protease in the reaction solution to obtain independent cyan fluorescent protein and yellow fluorescent protein, and the FRET phenomenon disappears, which enhances the cyan fluorescent signal. Therefore, the bactericidal activity of lysozyme against Gram-negative bacteria can be determined by quantitatively measuring the growth rate of the signal intensity of cyan fluorescent protein.
本发明所涉及的新型广谱溶菌酶的高通量筛选方法的具体操作如下:The specific operations of the high-throughput screening method of the novel broad-spectrum lysozyme involved in the present invention are as follows:
(1)构建表达目标溶菌酶基因突变文库的真核细胞:(1) Construction of eukaryotic cells expressing the target lysozyme gene mutation library:
目标溶菌酶的具体种类可根据实际需要选择。编码目标溶菌酶的基因序列通过核酸数据库查找并进行全基因合成,得到原始目标溶菌酶基因序列。构建目标溶菌酶基因随机突变文库主要通过易错PCR和DNA改组(也称DNA洗牌)两种手段实现。The specific type of target lysozyme can be selected according to actual needs. The gene sequence encoding the target lysozyme is searched through the nucleic acid database and the whole gene is synthesized to obtain the original target lysozyme gene sequence. The construction of the random mutation library of the target lysozyme gene is mainly realized by error-prone PCR and DNA shuffling (also called DNA shuffling).
1)易错PCR具体操作步骤如下:1) The specific operation steps of error-prone PCR are as follows:
针对原始目标溶菌酶基因序列设计含有酶切位点的引物,通过调整PCR反应体系的配比及反应条件,如改变反应体系中金属离子的浓度、增加PCR反应循环次数等,进行易错PCR扩增,使易错PCR产物中的基因序列发生点突变,从而引起氨基酸改变。Design primers containing restriction sites for the original target lysozyme gene sequence, and perform error-prone PCR amplification by adjusting the ratio and reaction conditions of the PCR reaction system, such as changing the concentration of metal ions in the reaction system, increasing the number of PCR reaction cycles, etc. Amplification, which causes point mutations in the gene sequence in error-prone PCR products, resulting in amino acid changes.
2)DNA改组具体操作步骤如下:2) The specific steps of DNA shuffling are as follows:
选取与原始目标溶菌酶基因具有同源性的其他溶菌酶基因序列,数目可以根据实际需要所选择。每种基因序列各取20μl混合,加入0.2U的DNaseI,16℃下酶切15min后立即加入6μl EDTA,转移至75℃水浴,酶失活10min。将酶切后的混合体系进行琼脂糖凝胶电泳,选取合适的方法,将所需大小的片段进行胶回收。若模板基因为2000bp左右,则切取100-200bp处胶块,选用胶回收试剂盒进行胶回收;若模板基因为1000bp左右,则切取50bp左右处胶块,由于片段长度小,电泳时选取低熔点琼脂糖进行电泳,切取的胶块溶在3倍体积的TE溶液中,利用酚氯仿抽提,再进行乙醇沉淀,回收小片段DNA。Select other lysozyme gene sequences that have homology with the original target lysozyme gene, and the number can be selected according to actual needs. Take 20 μl of each gene sequence and mix, add 0.2U DNaseI, digest at 16°C for 15 minutes, immediately add 6 μl EDTA, transfer to a 75°C water bath, and inactivate the enzyme for 10 minutes. Perform agarose gel electrophoresis on the mixed system after enzyme digestion, and select a suitable method to recover the fragments of the required size from the gel. If the template gene is about 2000bp, cut the gel block at 100-200bp, and use the gel recovery kit for gel recovery; if the template gene is about 1000bp, cut the gel block at about 50bp, because the fragment length is small, choose a low melting point during electrophoresis Agarose was electrophoresed, and the cut gel pieces were dissolved in 3 times the volume of TE solution, extracted with phenol-chloroform, and then ethanol-precipitated to recover small fragments of DNA.
将回收后的片段DNA作为无引物PCR的模板,进行无引物PCR,利用基因重组的原理,使片段DNA互为引物进行PCR,体系配比如下:1μl PFU酶,5μlbuffer,10μl DNTP,5μl片段DNA,29μl超纯水,共50μl。PCR程序为:94℃5min,94℃30s,46℃1min,72℃30s,50个循环,72℃10min。其中72℃延伸时间根据实际需要选定。对无引物PCR产物进行琼脂糖凝胶电泳,胶回收原始目标溶菌酶基因大小的片段。Use the recovered fragmented DNA as a primer-free PCR template for primerless PCR. Using the principle of genetic recombination, the fragmented DNA can be used as primers for PCR. The system mix is as follows: 1 μl PFU enzyme, 5 μl buffer, 10 μl DNTP, 5 μl fragmented DNA , 29 μl ultrapure water, a total of 50 μl. The PCR program was: 94°C for 5 min, 94°C for 30 s, 46°C for 1 min, 72°C for 30 s, 50 cycles, 72°C for 10 min. The elongation time at 72°C is selected according to actual needs. Agarose gel electrophoresis was performed on the primer-free PCR product, and the fragment of the size of the original target lysozyme gene was recovered from the gel.
根据几种同源基因设计含有相同酶切位点的引物,加入所设计的引物,利用上一步无引物PCR产物作为模板,进行有引物PCR。按常规PCR体系配比,按照正常PCR反应条件进行PCR反应。将有引物PCR产物再进行琼脂糖凝胶电泳,胶回收原始目标溶菌酶基因大小的片段。According to several homologous genes, primers containing the same restriction site were designed, and the designed primers were added, and the PCR products without primers in the previous step were used as templates to perform PCR with primers. According to the ratio of conventional PCR system, the PCR reaction was carried out according to the normal PCR reaction conditions. The PCR product with primers was subjected to agarose gel electrophoresis again, and the fragment of the size of the original target lysozyme gene was recovered from the gel.
将易错PCR或DNA改组后的产物进行双酶切,将表达载体也采用同样的酶进行双酶切,通过琼脂糖凝胶电泳,回收所需大小片段,取5μl回收产物再次进行电泳,根据条带亮度确定目的基因和表达载体比例,配制连接体系,16℃连接过夜,构建重组质粒。The product after error-prone PCR or DNA shuffling was subjected to double enzyme digestion, and the expression vector was also subjected to double enzyme digestion with the same enzyme, and the required size fragment was recovered by agarose gel electrophoresis, and 5 μl of the recovered product was subjected to electrophoresis again, according to Determine the ratio of the target gene and the expression vector according to the brightness of the band, prepare the ligation system, connect overnight at 16°C, and construct the recombinant plasmid.
将重组质粒转入Top10感受态细胞中,然后将转入重组质粒的感受态细胞悬液全部涂于平板上,每个直径90mm的平板上涂布100-200μl转入重组质粒的感受态细胞悬液,37℃培养16h左右。用无菌水将生长好的菌株从平板上冲下,形成菌悬液,回收菌悬液,利用提质粒试剂盒提取菌悬液中的重组质粒。Transfer the recombinant plasmid into Top10 competent cells, and then apply all the competent cell suspension transferred to the recombinant plasmid on the plate, and apply 100-200 μl of the competent cell suspension transferred to the recombinant plasmid on each plate with a diameter of 90 mm. solution, cultured at 37°C for about 16 hours. Wash the grown strains off the plate with sterile water to form a bacterial suspension, recover the bacterial suspension, and use a plasmid extraction kit to extract the recombinant plasmid in the bacterial suspension.
将重组质粒转入真核生物感受态细胞中,例如毕赤酵母感受态细胞,将转入重组质粒的真核生物感受态细胞悬液全部平分涂于平板上,静置培养,获得含目标溶菌酶基因突变文库的真核细胞。Transfer the recombinant plasmid into eukaryotic competent cells, such as Pichia pastoris competent cells, spread all the eukaryotic competent cell suspensions transferred into the recombinant plasmid on the plate, and culture it statically to obtain the target lysate Enzyme Gene Mutation Libraries for Eukaryotic Cells.
(2)构建胞内表达“供体荧光蛋白-蛋白酶的识别位点-受体荧光蛋白”的革兰氏阴性菌:(2) Construct a gram-negative bacterium that expresses "donor fluorescent protein-protease recognition site-acceptor fluorescent protein" in the cell:
所采用的供体荧光蛋白为青色荧光蛋白,受体荧光蛋白为光色荧光蛋白,蛋白酶为TEV蛋白酶;The donor fluorescent protein used is cyan fluorescent protein, the acceptor fluorescent protein is photochromic fluorescent protein, and the protease is TEV protease;
通过NCBI数据库查找出青色荧光蛋白和黄色荧光蛋白的基因序列,加入TEV蛋白酶的识别位点基因作为中间linker序列,设计出两端带有限制性酶切位点的“青色荧光蛋白-TEV蛋白酶的识别位点-黄色荧光蛋白”FRET荧光蛋白对基因序列,通过人工进行合成。将FRET荧光蛋白对基因和革兰氏阴性菌胞内表达载体均进行双酶切,电泳后回收片段进行连接,构建重组质粒。The gene sequences of cyan fluorescent protein and yellow fluorescent protein were found through the NCBI database, and the recognition site gene of TEV protease was added as the intermediate linker sequence, and the "cyan fluorescent protein-TEV protease gene" with restriction enzyme sites at both ends was designed. The recognition site-yellow fluorescent protein "FRET fluorescent protein pair gene sequence is artificially synthesized. Both the FRET fluorescent protein pair gene and the intracellular expression vector of Gram-negative bacteria were digested with double enzymes, and the fragments recovered after electrophoresis were ligated to construct a recombinant plasmid.
将重组质粒导入革兰氏阴性菌感受态细胞中,诱导发酵表达,通过SDS-PAGE鉴定FRET荧光蛋白对成功在菌种中得到表达。离心收集菌体,弃上清,加入无菌水重悬菌种,再离心后加入无菌水,使其形成具有特定浓度的菌悬液。The recombinant plasmid was introduced into Gram-negative bacterial competent cells, and the fermentation expression was induced, and the FRET fluorescent protein pair was successfully expressed in the strain identified by SDS-PAGE. Collect the bacteria by centrifugation, discard the supernatant, add sterile water to resuspend the bacteria, and then add sterile water after centrifugation to form a bacterial suspension with a specific concentration.
(3)筛选对革兰氏阴性菌杀菌活性高的溶菌酶:(3) Screening for lysozyme with high bactericidal activity against Gram-negative bacteria:
将成功分泌表达目标溶菌酶基因突变文库的酵母体系,逐孔转入装有酵母培养基的96深孔板中,在深孔板中进行诱导发酵,获得含目标溶菌酶的发酵液。The yeast system that successfully secretes and expresses the target lysozyme gene mutation library is transferred into a 96 deep-well plate filled with yeast medium one by one, and induced fermentation is carried out in the deep-well plate to obtain a fermentation broth containing the target lysozyme.
每孔吸取100μl发酵液,并将其逐孔对应地转移入透明的酶标板中,每孔再加入100μl纯水,混匀后在酶标仪中测得每孔发酵液的OD600值。Take 100 μl of fermentation broth from each well, and transfer it into a transparent microplate plate correspondingly, add 100 μl of pure water to each well, mix well and measure the OD 600 value of the fermentation broth in each well in a microplate reader.
向胞内表达“青色荧光蛋白-TEV蛋白酶的识别位点-黄色荧光蛋白”的革兰氏阴性菌的菌悬液中,加入TEV蛋白酶及TEV蛋白酶缓冲液,加入量根据检测量所需计算(检测时,每孔加入150μl菌悬液、0.8μl TEV蛋白酶缓冲液和0.5μl TEV蛋白酶),混匀后形成底物混合液,向荧光酶标板中每孔加入151μl底物混合液。Add TEV protease and TEV protease buffer to the bacterial suspension of Gram-negative bacteria expressing "cyan fluorescent protein-TEV protease recognition site-yellow fluorescent protein", and the amount added is calculated according to the detection amount ( For detection, add 150 μl of bacterial suspension, 0.8 μl of TEV protease buffer and 0.5 μl of TEV protease) to each well, mix well to form a substrate mixture, and add 151 μl of substrate mixture to each well of the fluorescent microplate.
然后向荧光酶标板中每孔加入50μl发酵液(最后两孔不加入发酵液,只加入底物混合液作为阴性对照),立即吸打1-2次后,放入酶标仪中进行检测,激发波长为433nm,发射波长为475nm,每隔1min检测一次,共检测45min,反应4h后,再检测10min,每隔1min检测一次。Then add 50 μl of fermentation broth to each well of the fluorescent microplate (no fermentation broth is added to the last two wells, only the substrate mixture is added as a negative control), pipette 1-2 times immediately, and then put it into a microplate reader for detection , the excitation wavelength is 433nm, and the emission wavelength is 475nm. The detection is performed every 1 minute for a total of 45 minutes.
筛选指标的处理分析如下:The processing and analysis of screening indicators are as follows:
反应前45min以时间(min)为横坐标、青色荧光信号强度值为纵坐标做图,检测反应开始时的稳定性。如果反应稳定,即反应趋势平缓上升,则可以求前10min荧光信号强度平均值,同时求反应4h后10min内的平均值。两个平均值之差再除以每孔发酵液的OD600值,即荧光信号强度差值/OD600(青色荧光蛋白的信号强度增长速度),以此数据对突变溶菌酶酶活的高低进行排序,同时将各孔的数据与阴性对照孔的数据进行比对。其中青色荧光信号增长越快且高于对照孔数值的,表示发酵液中的溶菌酶对革兰氏阴性菌杀菌活性越高。45 minutes before the reaction, take the time (min) as the abscissa and the cyan fluorescence signal intensity value as the ordinate to draw a graph to detect the stability at the beginning of the reaction. If the reaction is stable, that is, the reaction trend rises gently, the average value of the fluorescence signal intensity in the first 10 minutes can be calculated, and the average value within 10 minutes after 4 hours of reaction can be calculated at the same time. The difference between the two average values was divided by the OD 600 value of each well of the fermentation broth, that is, the difference in fluorescence signal intensity/OD 600 (the signal intensity growth rate of cyan fluorescent protein), and the activity of the mutant lysozyme was calculated based on this data. Sorting and comparing the data of each well with the data of the negative control well. Among them, the faster the cyan fluorescence signal increases and is higher than the value of the control well, it means that the lysozyme in the fermentation broth has a higher bactericidal activity on Gram-negative bacteria.
对筛选出的含对革兰氏阴性菌杀菌活性高的溶菌酶的阳性酵母进行放大培养和复筛,根据反应过程中青色荧光蛋白的信号强度增长速度,验证溶菌酶的活性。提取最终得到的阳性酵母的全基因组,扩增目的基因并进行测序,得到具有高革兰氏阴性菌杀菌活性的新型溶菌酶的基因序列。The screened positive yeast containing lysozyme with high bactericidal activity against Gram-negative bacteria was amplified and re-screened, and the activity of lysozyme was verified according to the growth rate of the signal intensity of cyan fluorescent protein during the reaction. The whole genome of the finally obtained positive yeast is extracted, the target gene is amplified and sequenced to obtain the gene sequence of a novel lysozyme with high bactericidal activity against Gram-negative bacteria.
本发明中所述的“柞蚕溶菌酶基因”为经密码子优化后的柞蚕溶菌酶基因。The "tussah lysozyme gene" described in the present invention is the codon-optimized tussah lysozyme gene.
实施例Example
为使本发明更加容易理解,下面将结合实施例来进一步详细说明本发明,这些实施例仅起说明性作用,并不局限于本发明的应用范围。本发明中所使用的原料或组分若无特殊说明均可以通过商业途径或常规方法制得。In order to make the present invention easier to understand, the present invention will be further described in detail below in conjunction with examples, and these examples are for illustrative purposes only, and do not limit the scope of application of the present invention. The raw materials or components used in the present invention can be prepared by commercial channels or conventional methods unless otherwise specified.
实施例1:构建柞蚕溶菌酶基因突变文库Example 1: Construction of tussah silkworm lysozyme gene mutation library
柞蚕是一种北方经济昆虫,柞蚕溶菌酶(Aplyz)具有适应温度范围广、最适温度较低等特性,具有良好的应用价值。由NCBI数据库中查找到柞蚕溶菌酶基因序列,成熟肽序列共363bp,由公司进行全基因合成,合成后的基因序列如下:Tussah silkworm is an economic insect in northern China. Tussah silkworm lysozyme (Aplyz) has the characteristics of wide temperature range and low optimum temperature, and has good application value. The tussah silkworm lysozyme gene sequence was found from the NCBI database. The mature peptide sequence is 363bp in total. The company carried out the whole gene synthesis. The synthesized gene sequence is as follows:
AAGTGGTTTACCAAATGTGGTCTAGTGCACGAGCTGAGGAGACAAGGCTTCGACGAGAGCCTAATGAGAGACTGGGTCTGTTTGGTTGAGAACGAAAGCAGCAGATATACTAATAAAATCGGTAAAGTGAATAAGAATGGTTCTCAAGACTACGGTTTGTTCCAGATCAATGACAAATATTGGTGTAGTAAGACCTCCACCCCCGGAAAGGATTGCAATGTGACTTGTAATCAATTGTTGACTGACGATATTACAGTTGCTGCTACCTGTGCGAAGAAGATTTACAAGAGACATAAGTTTAACGCTTGGTACGGATGGTTAAACCACTGTCAACACTCTCTTCCAGACATTAGCGACTGTTAA;AAGTGGTTTACCAAATGTGGTCTAGTGCACGAGCTGAGGAGACAAGGCTTCGACGAGAGCCTAATGAGAGACTGGGTCTGTTTGGTTGAGAACGAAAGCAGCAGATATACTAATAAAATCGGTAAAGTGAATAAGAATGGTTCTCAAGACTACGGTTTGTTCCAGATCAATGACAAATATTGGTGTAGTAAGACCTCCACCCCCGGAAAGGATTGCAATGTGACTTGTAATCAATTGTTGACTGACGATATTACAGTTGCTGCTACCTGTGCGAAGAAGATTTACAAGAGACATAAGTTTAACGCTTGGTACGGATGGTTAAACCACTGTCAACACTCTCTTCCAGACATTAGCGACTGTTAA;
根据要连接的表达载体pPICZαA和上述柞蚕溶菌酶基因序列,选择NotI和XhoI两种限制性内切酶,设计含有酶切位点的上下游引物,引物序列如下:According to the expression vector pPICZαA to be connected and the above-mentioned tussah silkworm lysozyme gene sequence, two restriction enzymes, NotI and XhoI, were selected, and upstream and downstream primers containing restriction sites were designed. The primer sequences are as follows:
Aplyz-F:TCTACTCGAGAAAAGAAAGTGGTTTACCAAplyz-F: TCTACTCGAGAAAAAGAAAGTGGTTTACCA
Aplyz-R:TCGCTGACAATTCGCCGGCGTATATAplyz-R: TCGCTGACAATTCGCCGGCGTATAT
首先进行正常PCR,扩增柞蚕溶菌酶基因,与T载体连接后留存菌种,后选用易错PCR和DNA改组两种方法构建柞蚕溶菌酶的基因突变文库。Firstly, normal PCR was carried out to amplify the gene of tussah lysozyme, and the strain was retained after being connected with T carrier, and then two methods of error-prone PCR and DNA shuffling were used to construct the gene mutation library of tussah silkworm lysozyme.
易错PCR的具体操作步骤如下:The specific operation steps of error-prone PCR are as follows:
以柞蚕溶菌酶基因为模板,加入设计好的上下游引物,调整体系配比以及反应条件,进行易错PCR,反应体系配比如下:Using the tussah silkworm lysozyme gene as a template, add the designed upstream and downstream primers, adjust the system ratio and reaction conditions, and perform error-prone PCR. The reaction system ratio is as follows:
PCR反应条件为94℃预变性3min,94℃变性1min,56℃退火30s,72℃延伸30s,共50个循环。1%琼脂糖凝胶电泳45min,凝胶成像仪检测并记录结果。The PCR reaction conditions were pre-denaturation at 94°C for 3 min, denaturation at 94°C for 1 min, annealing at 56°C for 30 s, and extension at 72°C for 30 s, a total of 50 cycles. 1% agarose gel electrophoresis for 45min, the gel imager was used to detect and record the results.
DNA改组的具体操作步骤如下:The specific steps of DNA shuffling are as follows:
选取与柞蚕溶菌酶基因序列具有同源性的人源溶菌酶基因4(LYZL4)的基因和人源溶菌酶基因6(LYZL6)的基因,对柞蚕溶菌酶基因进行改组。其中,人源溶菌酶基因4的基因序列如下:The genes of human lysozyme gene 4 (LYZL4) and human lysozyme gene 6 (LYZL6) which have homology with tussah silkworm lysozyme gene sequence were selected, and tussah silkworm lysozyme gene was shuffled. Wherein, the gene sequence of human lysozyme gene 4 is as follows:
GAATTCCTCGAGTACATCTTAGGTAGATGTACTGTCGCAAAGAAACTGCATGACGGAGGTCTGGATTACTTCGAAGGATACTCTCTTGAGAATTGGGTGTGCTTGGCCTATTTTGAGTCTAAGTTCAATCCAATGGCCATATATGAAAATACTAGAGAGGGTTATACCGGATTTGGATTGTTTCAGATGAGAGGTAGTGATTGGTGCGGTGACCATGGTAGAAACAGATGTCATATGTCATGTTCCGCATTATTGAACCCAAACCTTGAAAAAACTATTAAGTGCGCTAAAACTATTGTTAAGGGTAAAGAAGGTATGGGTGCTTGGCCTACCTGGTCTAGATATTGTCAATACAGTGATACATTGGCTAGATGGCTAGACGGATGTAAGCTTTAAGCGGCCGCGAATTCCTCGAGTACATCTTAGGTAGATGTACTGTCGCAAAGAAACTGCATGACGGAGGTCTGGATTACTTCGAAGGATACTCTCTTGAGAATTGGGTGTGCTTGGCCTATTTTGAGTCTAAGTTCAATCCAATGGCCATATATGAAAATACTAGAGAGGGTTATACCGGATTTGGATTGTTTCAGATGAGAGGTAGTGATTGGTGCGGTGACCATGGTAGAAACAGATGTCATATGTCATGTTCCGCATTATTGAACCCAAACCTTGAAAAAACTATTAAGTGCGCTAAAACTATTGTTAAGGGTAAAGAAGGTATGGGTGCTTGGCCTACCTGGTCTAGATATTGTCAATACAGTGATACATTGGCTAGATGGCTAGACGGATGTAAGCTTTAAGCGGCCGC
人源溶菌酶基因6的基因序列如下:The gene sequence of human lysozyme gene 6 is as follows:
GAATTCCTCGAGTCTTTGATTTCTAGATGCGATTTGGCTCAAGTTTTGCAGTTGGAGGACTTGGACGGTTTCGAGGGTTACTCTTTGTCTGACTGGTTGTGCTTGGCCTTCGTCGAGTCTAAGTTCAACATCTCTAAGATCAACGAGAACGCCGACGGATCTTTCGACTACGGATTGTTCCAGATCAACTCTCACTACTGGTGCAACGACTACAAATCTTACTCTGAGAACTTGTGCCATGTCGATTGCCAGGACTTGTTGAACCCAAACTTGTTGGCTGGAATCCATTGCGCCAAGAGAATCGTCTCTGGAGCCAGAGGAATGAACAACTGGGTCGAGTGGAGATTGCACTGCTCTGGTAGACCTTTGTTCTATTGGTTGACCGGTTGCAGATTGAGATGAGCGGCCGCGAATTCCTCGAGTCTTTGATTTCTAGATGCGATTTGGCTCAAGTTTTGCAGTTGGAGGACTTGGACGGTTTCGAGGGTTACTCTTTGTCTGACTGGTTGTGCTTGGCCTTCGTCGAGTCTAAGTTCAACATCTCTAAGATCAACGAGAACGCCGACGGATCTTTCGACTACGGATTGTTCCAGATCAACTCTCACTACTGGTGCAACGACTACAAATCTTACTCTGAGAACTTGTGCCATGTCGATTGCCAGGACTTGTTGAACCCAAACTTGTTGGCTGGAATCCATTGCGCCAAGAGAATCGTCTCTGGAGCCAGAGGAATGAACAACTGGGTCGAGTGGAGATTGCACTGCTCTGGTAGACCTTTGTTCTATTGGTTGACCGGTTGCAGATTGAGATGAGCGGCCGC
根据柞蚕溶菌酶基因序列、人源溶菌酶基因4基因序列和人源溶菌酶基因6基因序列设计含有相同酶切位点的引物。设计引物如下:Primers containing the same restriction sites were designed according to the tussah silkworm lysozyme gene sequence, human lysozyme gene 4 gene sequence and human lysozyme gene 6 gene sequence. Primers were designed as follows:
柞蚕溶菌酶基因、人源溶菌酶基因4、人源溶菌酶基因6各取20μl进行混合,加入6μl的DNaseI缓冲液,加入0.2U左右的DNaseI,酶切15min,加入10μlEDTA,75℃酶失活10min。酶切后的混合体系采用1.5%低熔点琼脂糖凝胶电泳45min,凝胶成像仪检测并记录结果。Take 20 μl of tussah silkworm lysozyme gene, human lysozyme gene 4, and human lysozyme gene 6, mix them, add 6 μl of DNaseI buffer, add about 0.2 U of DNaseI, digest for 15 minutes, add 10 μl of EDTA, and inactivate the enzyme at 75°C 10min. The mixed system after enzyme digestion was electrophoresed on 1.5% low-melting point agarose gel for 45 minutes, and the gel imager was used to detect and record the results.
选取50bp左右处条带,在紫外灯下将胶块切下,加入3倍体积TE溶液,放入70℃水浴中至凝胶熔化,加入等体积的平衡酚抽提一次,12000rpm离心10min取上清转入另一PE管中,去除多余的琼脂。用等体积的酚:(氯仿:异戊醇)(1:1)和氯仿:异戊醇(24:1)各抽提一次,取上清。Select the band at about 50bp, cut off the gel block under ultraviolet light, add 3 times the volume of TE solution, put it in a 70°C water bath until the gel melts, add an equal volume of balanced phenol to extract once, and centrifuge at 12000rpm for 10min to take it Cleared into another PE tube, remove excess agar. Use an equal volume of phenol:(chloroform:isoamyl alcohol) (1:1) and chloroform:isoamyl alcohol (24:1) to extract once each, and take the supernatant.
加入总体积1/10的乙酸钠(pH5.2),再加入三倍体积预冷的无水乙醇,混匀后在-20℃冰箱中冷冻过夜。将离心管取出,放入预冷的4℃离心机,13000rpm高速离心15min,将上清尽可能吸除干净后,向两离心管中各加入1ml 75%的冰冻乙醇,13000rpm,离心10min。重复加入1ml 75%的冰冻乙醇,再次除盐。室温下自然风干,向两支离心管中各加入13μL去离子水溶解DNA,后从离心管中各取3μL DNA溶液跑电泳检查乙醇沉淀后回收效果。Add 1/10 of the total volume of sodium acetate (pH 5.2), then add three times the volume of pre-cooled absolute ethanol, mix well and freeze overnight in a -20°C refrigerator. Take out the centrifuge tube, put it into a pre-cooled 4°C centrifuge, centrifuge at 13000rpm for 15min at high speed, suck up the supernatant as much as possible, add 1ml of 75% frozen ethanol to each of the two centrifuge tubes, centrifuge at 13000rpm for 10min. Desalt again by repeatedly adding 1 ml of 75% ice-cold ethanol. Naturally air-dry at room temperature, add 13 μL deionized water to each of the two centrifuge tubes to dissolve the DNA, and then take 3 μL of the DNA solution from each centrifuge tube to run electrophoresis to check the recovery effect after ethanol precipitation.
以回收的小片段DNA产物为模板,不加引物,利用同源重组,使小片段之间互相作为模板,进行无引物PCR,体系如下:Using the recovered small fragment DNA product as a template, without adding primers, using homologous recombination, the small fragments serve as templates for each other, and perform primer-free PCR. The system is as follows:
PCR反应条件为94℃预变性5min,94℃变性30s,46℃退火1min,72℃延伸30s,共50个循环,最后72℃延伸10min。对无引物PCR产物采用1%琼脂糖凝胶电泳45min,凝胶成像仪检测并记录结果,并利用胶回收试剂盒回收400bp左右处DNA。为了增加片段的丰富性,可再次利用DNaseI进行酶切并无引物PCR,再次回收。The PCR reaction conditions were pre-denaturation at 94°C for 5 min, denaturation at 94°C for 30 s, annealing at 46°C for 1 min, extension at 72°C for 30 s, a total of 50 cycles, and a final extension at 72°C for 10 min. Use 1% agarose gel electrophoresis for 45min on the PCR products without primers, detect and record the results with a gel imager, and recover the DNA at about 400bp using the gel recovery kit. In order to increase the richness of the fragments, DNaseI can be used again for enzyme digestion and PCR without primers, and the fragments can be recovered again.
利用无引物PCR产物为模板,加入上述的六种引物,进行有引物PCR,体系如下:Use the PCR product without primers as a template, add the above six primers, and perform PCR with primers. The system is as follows:
PCR反应条件为:94℃预变性5min,94℃变性1min,55.5℃退火30s,72℃延伸30s,共33个循环,最后72℃延伸10min。扩增产物采用1%琼脂糖凝胶电泳45min,凝胶成像仪检测并记录结果,并利用胶回收试剂盒回收400bp左右处DNA。The PCR reaction conditions were: pre-denaturation at 94°C for 5 min, denaturation at 94°C for 1 min, annealing at 55.5°C for 30 s, extension at 72°C for 30 s, a total of 33 cycles, and finally extension at 72°C for 10 min. The amplified product was electrophoresed on a 1% agarose gel for 45 minutes, detected by a gel imager and recorded, and the DNA at about 400 bp was recovered using a gel recovery kit.
选用NotI和XhoI限制性内切酶,对易错PCR产物和DNA改组产物以及表达质粒pPICZαA进行双酶切。双酶切后对体系进行电泳,回收所需大小片段,再次将胶回收产物进行电泳,根据条带亮度判断浓度比例,将目的基因和表达质粒连接过夜,构成重组表达质粒。NotI and XhoI restriction endonucleases were selected to perform double enzyme digestion on the error-prone PCR product, the DNA shuffling product and the expression plasmid pPICZαA. After double digestion, electrophoresis was performed on the system to recover fragments of the required size, and the gel-recovered product was electrophoresed again, and the concentration ratio was judged according to the brightness of the bands, and the target gene and expression plasmid were connected overnight to form a recombinant expression plasmid.
将重组质粒转入Top10感受态细胞中,后将转入重组质粒的感受态细胞悬液全部涂于平板上,每个直径90mm的平板上涂布100-200μl转入重组质粒的感受态细胞悬液,37℃培养16h左右。用无菌水将生长好的菌株从平板上冲下,形成菌悬液,回收菌悬液,利用提质粒试剂盒提取菌悬液中的重组质粒。Transfer the recombinant plasmid into Top10 competent cells, and then apply all the competent cell suspension transferred to the recombinant plasmid on the plate, and apply 100-200 μl of the competent cell suspension transferred to the recombinant plasmid on each plate with a diameter of 90 mm. solution, cultured at 37°C for about 16 hours. Wash the grown strains off the plate with sterile water to form a bacterial suspension, recover the bacterial suspension, and use a plasmid extraction kit to extract the recombinant plasmid in the bacterial suspension.
实施例2:将重组表达质粒转入毕赤酵母细胞Example 2: Transferring recombinant expression plasmids into Pichia pastoris cells
毕赤酵母表达系统是一种良好的真核表达系统,结合pPICZαA表达质粒可以实现良好的胞外表达。Pichia pastoris expression system is a good eukaryotic expression system, combined with pPICZαA expression plasmid can achieve good extracellular expression.
毕赤酵母感受态细胞制备具体操作步骤如下:The specific operation steps for the preparation of Pichia pastoris competent cells are as follows:
(1)挑取YPDS平板上的毕赤酵母GS115单克隆接种于10ml YPD液体培养基中,为保证通气量,用6层纱布封口,30℃,250rpm培养过夜。(1) Pick a single clone of Pichia pastoris GS115 on the YPDS plate and inoculate it in 10 ml of YPD liquid medium. To ensure ventilation, seal it with 6 layers of gauze and culture overnight at 30°C and 250rpm.
(2)按1%的接种量转接于含50ml YPD液体培养基的250ml带挡板锥形瓶中。30℃,250rpm震荡培养约20h至OD600为1.3-1.5。(2) Transfer to a 250ml Erlenmeyer flask with baffles containing 50ml YPD liquid medium according to the inoculum size of 1%. Cultivate at 30°C with shaking at 250rpm for about 20h until the OD 600 is 1.3-1.5.
(3)将菌液移入预冷的50ml的离心管中,冰浴至少30min,使细胞充分冷却,4℃,4000rpm,离心5min收集细胞。(3) Transfer the bacterial solution into a pre-cooled 50ml centrifuge tube, place in an ice bath for at least 30 minutes to fully cool the cells, and collect the cells by centrifugation at 4°C and 4000 rpm for 5 minutes.
(4)小心弃上清液,用50ml冰预冷的无菌去离子水重悬菌体,4℃,4 000rpm,离心5min。(4) Carefully discard the supernatant, resuspend the bacteria in 50ml ice-cold sterile deionized water, centrifuge at 4000rpm at 4°C for 5min.
(5)用25ml冰预冷的无菌去离子水再次重悬菌体。(5) Resuspend the bacteria again with 25ml of ice-cold sterile deionized water.
(6)小心弃上清,用5ml冰预冷的1mol/L的山梨醇溶液重悬细胞菌体,4℃,4000rpm,离心5min。(6) Carefully discard the supernatant, resuspend the cells with 5ml ice-cold 1mol/L sorbitol solution, centrifuge at 4000rpm at 4°C for 5min.
(7)小心弃上清液,用1ml山梨醇重悬菌体,按每管80μL分装备用。(7) Carefully discard the supernatant, resuspend the cells with 1ml sorbitol, and dispense 80μL per tube for use.
重组质粒电转化入毕赤酵母GS115感受态细胞的具体步骤如下:The specific steps for the electrotransformation of recombinant plasmids into Pichia pastoris GS115 competent cells are as follows:
(1)将10μL线性化的重组质粒pPICZαA-ApLyz加入80μL毕赤酵母GS115感受态细胞中,冰上预冷10min。(1) Add 10 μL of the linearized recombinant plasmid pPICZαA-ApLyz to 80 μL of Pichia pastoris GS115 competent cells, and pre-cool on ice for 10 min.
(2)将电转仪的电转电压调节到1.5kV。(2) Adjust the electrotransfer voltage of the electrotransfer instrument to 1.5kV.
(3)将冰浴后的混合液加入到0.2cm预冷的电转杯中,轻扣几下,使混合液沉到电转杯底部,轻轻拭去电转杯外的水。(3) Add the ice-bathed mixture into the 0.2cm pre-cooled electric cup, tap it a few times to make the mixture sink to the bottom of the electric cup, and gently wipe off the water outside the electric cup.
(4)将电转杯放入电转仪中,电击时间约5.0ms,电击结束后立即加入1ml预冷的1mol/L的山梨醇溶液。(4) Put the electroporation cup into the electroporation apparatus, and the electroporation time is about 5.0 ms. Immediately after electroporation, 1 ml of pre-cooled 1 mol/L sorbitol solution is added.
(5)将电击后的菌液移入无菌离心管中,30℃静置培养1h后加入500μLYPD液体培养基轻轻混匀,继续静置复苏1h。(5) Transfer the electroshocked bacterial solution into a sterile centrifuge tube, incubate at 30°C for 1 hour, then add 500 μL of YPD liquid medium and mix gently, and continue to recover for 1 hour.
(6)复苏液涂布于含较低浓度Zeocin(100μg/ml)抗性的YPDS筛选平板上,每个平板涂布200μL,将全部复苏液涂完。(6) The resuscitation solution was spread on the YPDS screening plate containing a lower concentration of Zeocin (100 μg/ml) resistance, 200 μL was applied to each plate, and all the resuscitation solution was coated.
(7)30℃恒温静置培养48h。(7) Static culture at 30°C for 48 hours.
实施例3:构建胞内表达“青色荧光蛋白-TEV蛋白酶的识别位点-黄色荧光蛋白”的大肠杆菌Example 3: Construction of Escherichia coli expressing "cyan fluorescent protein-TEV protease recognition site-yellow fluorescent protein" in the cell
大肠杆菌是一种典型的革兰氏阴性菌,方便得到,易操作易培养,细胞壁具有脂多糖外膜,溶菌酶对其裂解效果较差。Escherichia coli is a typical Gram-negative bacterium, which is convenient to obtain, easy to operate and cultivate, and has a lipopolysaccharide outer membrane on the cell wall, so lysozyme has a poor cleavage effect on it.
根据NCBI数据库中查找到的荧光蛋白基因和TEV蛋白酶的识别位点基因序列,合成两端分别含有XhoI、NocI酶切位点的“青色荧光蛋白-TEV蛋白酶的识别位点-黄色荧光蛋白”基因序列。利用两种限制性内切酶分别对含有该蛋白对基因的克隆质粒和表达质粒pET28a进行双酶切,电泳回收所需片段。配制连接体系,将荧光蛋白对基因和表达质粒pET28a过夜连接,构建重组表达质粒。According to the fluorescent protein gene and TEV protease recognition site gene sequences found in the NCBI database, the "cyan fluorescent protein-TEV protease recognition site-yellow fluorescent protein" gene was synthesized with XhoI and NocI restriction sites at both ends. sequence. The cloning plasmid and expression plasmid pET28a containing the protein pair gene were double-digested with two restriction endonucleases respectively, and the desired fragment was recovered by electrophoresis. Prepare the connection system, connect the fluorescent protein pair gene and the expression plasmid pET28a overnight, and construct the recombinant expression plasmid.
取出BL21(DE3)感受态细胞在冰上融化1-2min,将过夜连接体系全部加入感受态细胞中,冰浴30min后转入42℃水浴90s,立即转入冰中2-3min后,每管加入900μl LB培养基,37℃200rpm复苏1h。将复苏好的菌悬液吸取100μl涂于含有卡那霉素的LB平板上。Take out BL21(DE3) competent cells and thaw on ice for 1-2min, add all the overnight ligation system to the competent cells, and then transfer to 42°C water bath for 90s in ice bath for 30min, then immediately transfer to ice for 2-3min, each tube Add 900 μl LB medium, recover at 200 rpm at 37°C for 1 hour. Aspirate 100 μl of the recovered bacterial suspension and spread it on the LB plate containing kanamycin.
利用pET28a通用引物,对平板上长出菌落进行菌落PCR扩增,验证成功转入质粒的大肠杆菌,然后进行发酵,发酵具体步骤如下:Use the pET28a universal primer to perform colony PCR amplification on the colonies grown on the plate, verify the Escherichia coli successfully transformed into the plasmid, and then carry out fermentation. The specific steps of fermentation are as follows:
1)将成功转入重组表达质粒的大肠杆菌转入50ml含有适量卡那霉素的LB液体培养基(锥形瓶,250ml规格),37℃摇床培养至OD600为0.4-1之间,最好为0.6,大约3h。1) Transfer the Escherichia coli successfully transformed into the recombinant expression plasmid into 50ml LB liquid medium (conical flask, 250ml specification) containing an appropriate amount of kanamycin, and culture it on a shaker at 37°C until the OD600 is between 0.4-1, The best is 0.6, about 3h.
2)取现制的浓度为100mM的IPTG 0.5ml加入一组培养基中,使其工作浓度为1mM(由于pET28a含有T7lac启动子,如果其他质粒含有T7启动子,则将IPTG工作浓度稀释为0.4mM);另一组培养基不加IPTG,作对照,将两组继续摇床培养3h。2) Take 0.5ml of the prepared IPTG with a concentration of 100mM and add it to a group of medium to make the working concentration 1mM (because pET28a contains T7lac promoter, if other plasmids contain T7 promoter, dilute the working concentration of IPTG to 0.4mM ); another group of culture medium without IPTG was used as a control, and the two groups were cultured on a shaker for 3 h.
3)将锥形瓶在冰上放置5min后,4℃5000×g离心5min,弃上清,菌体用1/4容器体积经预冷的无菌水重悬菌种,再次离心,4℃5000×g离心5min。3) Place the Erlenmeyer flask on ice for 5 minutes, centrifuge at 5000×g at 4°C for 5 minutes, discard the supernatant, resuspend the bacteria in 1/4 container volume of pre-cooled sterile water, centrifuge again, and set at 4°C Centrifuge at 5000×g for 5 minutes.
4)无菌水重悬菌种。4) Resuspend the strains in sterile water.
实施例4:筛选对大肠杆菌杀菌活性高的新型柞蚕溶菌酶Example 4: Screening for novel tussah lysozyme with high bactericidal activity against Escherichia coli
将YPD平板上长好的带有溶菌酶基因的毕赤酵母,挑入装有1ml BMGY培养基的96深孔板中,一个菌种挑入一个孔中,培养3天后,4000rpm离心20min,弃上清,每孔加入1ml的BMMY培养基,加入20μl甲醇,每隔24h每孔加入20μl甲醇诱导发酵表达,发酵72h后停止发酵。Pick the Pichia pastoris with the lysozyme gene grown on the YPD plate into a 96-deep well plate filled with 1ml of BMGY medium, pick one strain into one well, and after culturing for 3 days, centrifuge at 4000rpm for 20min, discard For the supernatant, add 1ml of BMMY medium to each well, add 20μl of methanol, add 20μl of methanol to each well every 24h to induce fermentation expression, and stop the fermentation after 72h of fermentation.
将表达好的发酵液每孔吸取100μl,孔孔对应的转移入透明的正常96孔板后,每孔再加入100μl水,吹打混匀,放入酶标仪中测得OD600值。Pipette 100 μl of the expressed fermentation broth into each well, and transfer the corresponding wells into a transparent normal 96-well plate, then add 100 μl of water to each well, mix well by pipetting, and put it into a microplate reader to measure the OD 600 value.
向胞内表达荧光蛋白对的大肠杆菌菌悬液中,加入TEV蛋白酶及TEV蛋白酶缓冲液,加入量根据检测量所需计算(检测时,每孔加入150μl菌悬液、0.8μl TEV蛋白酶缓冲液和0.5μl TEV蛋白酶),混合好后形成底物混合液,向黑色96孔板中每孔加入151μl底物混合液。Add TEV protease and TEV protease buffer to the Escherichia coli suspension expressing fluorescent protein pairs in the cells, and the amount added is calculated according to the detection amount (when testing, add 150 μl of bacterial suspension and 0.8 μl of TEV protease buffer to each well) and 0.5 μl TEV protease), mix well to form a substrate mixture, and add 151 μl substrate mixture to each well of a black 96-well plate.
向黑色96孔板中每孔加入50μl发酵液(最后两孔不加入发酵液,只加入底物混合液作为阴性对照),立即吸打1-2次,放入酶标仪中进行检测,激发波长为433nm,发射波长为475nm,每隔1min检测一次,共检测45min中,反应4h后,再检测10min,每隔1min检测一次。Add 50 μl of fermentation broth to each well of the black 96-well plate (no fermentation broth is added to the last two wells, only the substrate mixture is added as a negative control), pipette 1-2 times immediately, put into a microplate reader for detection, and stimulate The wavelength is 433nm, and the emission wavelength is 475nm. It is detected once every 1 minute for a total of 45 minutes. After 4 hours of reaction, it is detected again for 10 minutes, and it is detected every 1 minute.
检测后,将数据经前文所说方法分析处理,得到含对大肠杆菌杀菌活性高的溶菌酶的酵母菌种,将菌种扩大培养,诱导发酵,进行复筛,将数据经前文所说方法分析处理,验证其活性。提取最终得到的阳性酵母的全基因组,扩增目的基因并进行测序,得到具有高革兰氏阴性菌杀菌活性的新型溶菌酶的基因序列。After the detection, the data were analyzed and processed by the method mentioned above to obtain yeast strains containing lysozyme with high bactericidal activity against Escherichia coli. The strains were expanded and cultivated, induced to ferment, and re-screened, and the data were analyzed by the method mentioned above processing to verify its activity. The whole genome of the finally obtained positive yeast is extracted, the target gene is amplified and sequenced to obtain the gene sequence of a novel lysozyme with high bactericidal activity against Gram-negative bacteria.
应当注意的是,以上所述的实施例仅用于解释本发明,并不构成对本发明的任何限制。通过参照典型实施例对本发明进行了描述,但应当理解为其中所用的词语为描述性和解释性词汇,而不是限定性词汇。可以按规定在本发明权利要求的范围内对本发明作出修改,以及在不背离本发明的范围和精神内对本发明进行修订。尽管其中描述的本发明涉及特定的方法、材料和实施例,但是并不意味着本发明限于其中公开的特定例,相反,本发明可扩展至其他所有具有相同功能的方法和应用。It should be noted that the above-mentioned embodiments are only used to explain the present invention, and do not constitute any limitation to the present invention. The invention has been described with reference to typical embodiments, but the words which have been used therein are words of description and explanation rather than words of limitation. The present invention can be modified within the scope of the claims of the present invention as prescribed, and the present invention can be revised without departing from the scope and spirit of the present invention. Although the invention described therein refers to specific methods, materials and examples, it is not intended that the invention be limited to the specific examples disclosed therein, but rather, the invention extends to all other methods and applications having the same function.
SEQUENCE LISTINGSEQUENCE LISTING
<110> 北京工商大学<110> Beijing Technology and Business University
<120> 一种新型广谱溶菌酶的高通量筛选方法<120> A high-throughput screening method for a novel broad-spectrum lysozyme
<130> 2017<130> 2017
<160> 12<160> 12
<170> PatentIn version 3.3<170> PatentIn version 3.3
<210> 1<210> 1
<211> 29<211> 29
<212> DNA<212>DNA
<213> Aplyz-F<213> Aplyz-F
<400> 1<400> 1
tctactcgag aaaagaaagt ggtttacca 29tctactcgag aaaagaaagt ggtttacca 29
<210> 2<210> 2
<211> 25<211> 25
<212> DNA<212>DNA
<213> Aplyz-R<213> Aplyz-R
<400> 2<400> 2
tcgctgacaa ttcgccggcg tatat 25tcgctgacaa ttcgccggcg tatat 25
<210> 3<210> 3
<211> 29<211> 29
<212> DNA<212>DNA
<213> 柞蚕溶菌酶上游引物<213> Tussah lysozyme upstream primer
<400> 3<400> 3
tctactcgag aaaagaaagt ggtttacca 29tctactcgag aaaagaaagt ggtttacca 29
<210> 4<210> 4
<211> 25<211> 25
<212> DNA<212>DNA
<213> 柞蚕溶菌酶下游引物<213> Tussah lysozyme downstream primer
<400> 4<400> 4
tatatgcggc cgcttaacag tcgct 25tatatgcggc cgcttaacag tcgct 25
<210> 5<210> 5
<211> 31<211> 31
<212> DNA<212>DNA
<213> 人源溶菌酶4上游引物<213> human lysozyme 4 upstream primer
<400> 5<400> 5
tctactcgag tacatcttag gtagatgtac t 31tctactcgag tacatcttag gtagatgtac t 31
<210> 6<210> 6
<211> 23<211> 23
<212> DNA<212>DNA
<213> 人源溶菌酶4下游引物<213> human lysozyme 4 downstream primer
<400> 6<400> 6
tatatgcggc cgcttaaagc tta 23tatatgcggc cgcttaaagc tta 23
<210> 7<210> 7
<211> 27<211> 27
<212> DNA<212>DNA
<213> 人源溶菌酶基因6上游引物<213> Human lysozyme gene 6 upstream primer
<400> 7<400> 7
tctactcgag tctttgattt ctagatg 27tctactcgag tctttgattt ctagatg 27
<210> 8<210> 8
<211> 23<211> 23
<212> DNA<212>DNA
<213> 人源溶菌酶基因6下游引物<213> Downstream primer of human lysozyme gene 6
<400> 8<400> 8
tatatgcggc cgctcatctc aat 23tatatgcggc cgctcatctc aat 23
<210> 9<210> 9
<211> 363<211> 363
<212> DNA<212>DNA
<213> 柞蚕溶菌酶基因<213> Tussah lysozyme gene
<400> 9<400> 9
aagtggttta ccaaatgtgg tctagtgcac gagctgagga gacaaggctt cgacgagagc 60aagtggttta ccaaatgtgg tctagtgcac gagctgagga gacaaggctt cgacgagagc 60
ctaatgagag actgggtctg tttggttgag aacgaaagca gcagatatac taataaaatc 120ctaatgagag actgggtctg tttggttgag aacgaaagca gcagatatac taataaaatc 120
ggtaaagtga ataagaatgg ttctcaagac tacggtttgt tccagatcaa tgacaaatat 180ggtaaagtga ataagaatgg ttctcaagac tacggtttgt tccagatcaa tgacaaatat 180
tggtgtagta agacctccac ccccggaaag gattgcaatg tgacttgtaa tcaattgttg 240tggtgtagta agacctccac ccccggaaag gattgcaatg tgacttgtaa tcaattgttg 240
actgacgata ttacagttgc tgctacctgt gcgaagaaga tttacaagag acataagttt 300actgacgata ttacagttgc tgctacctgt gcgaagaaga ttacaagag acataagttt 300
aacgcttggt acggatggtt aaaccactgt caacactctc ttccagacat tagcgactgt 360aacgcttggt acggatggtt aaaccactgt caacactctc ttccagacat tagcgactgt 360
taa 363taa 363
<210> 10<210> 10
<211> 404<211> 404
<212> DNA<212>DNA
<213> 人源溶菌酶基因4<213> Human lysozyme gene 4
<400> 10<400> 10
gaattcctcg agtacatctt aggtagatgt actgtcgcaa agaaactgca tgacggaggt 60gaattcctcg agtacatctt aggtagatgt actgtcgcaa agaaactgca tgacggaggt 60
ctggattact tcgaaggata ctctcttgag aattgggtgt gcttggccta ttttgagtct 120ctggattact tcgaaggata ctctcttgag aattgggtgt gcttggccta ttttgagtct 120
aagttcaatc caatggccat atatgaaaat actagagagg gttataccgg atttggattg 180aagttcaatc caatggccat atatgaaaat actagagagg gttataccgg atttggattg 180
tttcagatga gaggtagtga ttggtgcggt gaccatggta gaaacagatg tcatatgtca 240tttcagatga gaggtagtga ttggtgcggt gaccatggta gaaacagatg tcatatgtca 240
tgttccgcat tattgaaccc aaaccttgaa aaaactatta agtgcgctaa aactattgtt 300tgttccgcat tattgaaccc aaaccttgaa aaaactatta agtgcgctaa aactattgtt 300
aagggtaaag aaggtatggg tgcttggcct acctggtcta gatattgtca atacagtgat 360aagggtaaag aaggtatggg tgcttggcct acctggtcta gatattgtca atacagtgat 360
acattggcta gatggctaga cggatgtaag ctttaagcgg ccgc 404acattggcta gatggctaga cggatgtaag ctttaagcgg ccgc 404
<210> 11<210> 11
<211> 410<211> 410
<212> DNA<212>DNA
<213> 人源溶菌酶基因6<213> Human lysozyme gene 6
<400> 11<400> 11
gaattcctcg agtctttgat ttctagatgc gatttggctc aagttttgca gttggaggac 60gaattcctcg agtctttgat ttctagatgc gatttggctc aagttttgca gttggaggac 60
ttggacggtt tcgagggtta ctctttgtct gactggttgt gcttggcctt cgtcgagtct 120ttggacggtt tcgagggtta ctctttgtct gactggttgt gcttggcctt cgtcgagtct 120
aagttcaaca tctctaagat caacgagaac gccgacggat ctttcgacta cggattgttc 180aagttcaaca tctctaagat caacgagaac gccgacggat ctttcgacta cggattgttc 180
cagatcaact ctcactactg gtgcaacgac tacaaatctt actctgagaa cttgtgccat 240cagatcaact ctcactactg gtgcaacgac tacaaatctt actctgagaa cttgtgccat 240
gtcgattgcc aggacttgtt gaacccaaac ttgttggctg gaatccattg cgccaagaga 300gtcgattgcc aggacttgtt gaacccaaac ttgttggctg gaatccattg cgccaagaga 300
atcgtctctg gagccagagg aatgaacaac tgggtcgagt ggagattgca ctgctctggt 360atcgtctctg gagccagagg aatgaacaac tgggtcgagt ggagattgca ctgctctggt 360
agacctttgt tctattggtt gaccggttgc agattgagat gagcggccgc 410agacctttgt tctattggtt gaccggttgc agattgagat gagcggccgc 410
<170> 手工<170> manual
<210> 12<210> 12
<211> 7<211> 7
<212> PRT<212> PRT
<213> TEV蛋白酶识别位点<213> TEV protease recognition site
<400> 12<400> 12
Glu Asn Leu Tyr Phe Gln GlyGlu Asn Leu Tyr Phe Gln Gly
1 51 5
Claims (10)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710284625.9A CN107164457B (en) | 2017-04-26 | 2017-04-26 | High-throughput screening method of broad-spectrum lysozyme |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710284625.9A CN107164457B (en) | 2017-04-26 | 2017-04-26 | High-throughput screening method of broad-spectrum lysozyme |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN107164457A true CN107164457A (en) | 2017-09-15 |
| CN107164457B CN107164457B (en) | 2021-01-26 |
Family
ID=59813247
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201710284625.9A Active CN107164457B (en) | 2017-04-26 | 2017-04-26 | High-throughput screening method of broad-spectrum lysozyme |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN107164457B (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113846076A (en) * | 2021-08-23 | 2021-12-28 | 青岛农业大学 | Screening method of lysozyme with escherichia coli cracking capability and antibiotic |
Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1088233A2 (en) * | 1998-06-16 | 2001-04-04 | Biosignal Packard Inc. | A bioluminescence resonance energy transfer (bret) system and its use |
| CN1396265A (en) * | 2001-05-24 | 2003-02-12 | 香港科技大学 | A Method for Detecting Cell Apoptosis Based on Green Fluorescent Protein |
| JP2003321314A (en) * | 2002-02-28 | 2003-11-11 | Pharmafoods Kenkyusho:Kk | Antibacterial composition, its manufacturing method and antibacterial agent containing antibacterial composition |
| CN101037710A (en) * | 2006-12-27 | 2007-09-19 | 华中科技大学 | Polynucleotide sequence for detecting matrix metal proteinase activity |
| US20090324500A1 (en) * | 2006-05-19 | 2009-12-31 | Stephen Andrew Renshaw | Screen for inflammatory response modulators |
| CN105861468A (en) * | 2016-06-07 | 2016-08-17 | 江南大学 | Method for improving antibacterial property of pig lysozyme by fusing N-terminal with HLH functional domain |
| CN106011110A (en) * | 2016-06-23 | 2016-10-12 | 浙江工商大学 | Lysozyme with covalent modification through acyl-free sophorolipid derivatives and modifying method and application of lysozyme |
-
2017
- 2017-04-26 CN CN201710284625.9A patent/CN107164457B/en active Active
Patent Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1088233A2 (en) * | 1998-06-16 | 2001-04-04 | Biosignal Packard Inc. | A bioluminescence resonance energy transfer (bret) system and its use |
| CN1396265A (en) * | 2001-05-24 | 2003-02-12 | 香港科技大学 | A Method for Detecting Cell Apoptosis Based on Green Fluorescent Protein |
| JP2003321314A (en) * | 2002-02-28 | 2003-11-11 | Pharmafoods Kenkyusho:Kk | Antibacterial composition, its manufacturing method and antibacterial agent containing antibacterial composition |
| US20090324500A1 (en) * | 2006-05-19 | 2009-12-31 | Stephen Andrew Renshaw | Screen for inflammatory response modulators |
| CN101037710A (en) * | 2006-12-27 | 2007-09-19 | 华中科技大学 | Polynucleotide sequence for detecting matrix metal proteinase activity |
| CN105861468A (en) * | 2016-06-07 | 2016-08-17 | 江南大学 | Method for improving antibacterial property of pig lysozyme by fusing N-terminal with HLH functional domain |
| CN106011110A (en) * | 2016-06-23 | 2016-10-12 | 浙江工商大学 | Lysozyme with covalent modification through acyl-free sophorolipid derivatives and modifying method and application of lysozyme |
Non-Patent Citations (5)
| Title |
|---|
| HU, HAI-YU等: "FRET-based and other fluorescent proteinase probes", 《BIOTECHNOLOGY JOURNAL》 * |
| JUCOVIC, M等: "Delineation of an evolutionary salvage pathway by compensatory mutations of a defective lysozyme", 《PROTEIN SCIENCE》 * |
| 王成等: "《生物医学光学》", 28 February 2017, 东南大学出版社 * |
| 续丹丹等: "柞蚕溶菌酶真核表达系统的构建及重组蛋白纯化分析", 《饲料研究》 * |
| 邢艳珑等: "应用荧光分析法检测酶的研究进展", 《生物工程学报》 * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113846076A (en) * | 2021-08-23 | 2021-12-28 | 青岛农业大学 | Screening method of lysozyme with escherichia coli cracking capability and antibiotic |
Also Published As
| Publication number | Publication date |
|---|---|
| CN107164457B (en) | 2021-01-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN105200028B (en) | Endolysin and its application from vibrio parahaemolyticus phage | |
| WO2013087043A1 (en) | Flavobacterium strain, endo-alginate lyase encoding gene, and preparation and use of said gene | |
| CN104593346B (en) | A kind of endolysin and its application from vibrio parahaemolyticus phage | |
| CN101228271B (en) | Method for bacillus coli to high effectively excrine representing lysostaphin | |
| CN106636050A (en) | Broad-spectrum endolysin derived from methicillin-resistant staphylococcus aureus bacteriophage and application thereof | |
| CN104830825B (en) | A kind of endolysin and its application from salmonella bacteriophage | |
| WO2025011106A1 (en) | Biosynthesis method for broad-spectrum antiviral polypeptide | |
| CN118440967A (en) | SPRR2A prokaryotic expression system with antibacterial activity and construction method and application thereof | |
| CN107164457A (en) | A kind of high-throughput screening method of New-type wide-spectrum lysozyme | |
| CN111876400B (en) | Normal temperature lyase Sly and polynucleotide for coding same | |
| CN113214364B (en) | Mining and verification of a recognition element of multi-drug resistant Acinetobacter baumannii | |
| CN110452895B (en) | A kind of lysozyme derived from bacteriophage and its gene and application | |
| WO2025251550A1 (en) | Peptidoglycan hydrolase lysph1 having broad-spectrum lytic activity, and mutant and use thereof | |
| CN109609485B (en) | Chitin deacetylase and application thereof | |
| CN114106197B (en) | Narrow-spectrum antibacterial peptide and application thereof | |
| CN108823193B (en) | A high-efficiency Streptococcus pneumoniae chimeric lyase and its mutants and applications | |
| CN108220273A (en) | A kind of antimicrobial peptide mixture and its preparation method and application | |
| CN108864273B (en) | Simulated human-derived antibacterial peptide and preparation method thereof | |
| CN114317787A (en) | Adsorption magnetic beads, kit and use thereof, and method for detecting Staphylococcus aureus | |
| CN1888052A (en) | Separation and purification of protein BS2 resisting cotton blight and verticillium wilt and cloning of BS2 gene | |
| CN114958884B (en) | Gene construction and application method capable of rapidly detecting pullulan | |
| CN114107271B (en) | Heat-resistant and nutrient-resistant salmonella broad spectrum lyase with in-vitro cleavage activity, and preparation and application thereof | |
| CN120098090B (en) | A perforin derived from Staphylococcus warwick temperate phage and its application | |
| CN114106170B (en) | Amino acid sequence of anti-field halichondrin single-chain antibody and expression vector thereof | |
| CN111394375B (en) | Gene for coding beta-glucosidasemg163And uses thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant |